EG
Elizabeth Gerstner
Brain NeoplasmsGlioblastomaglioblastomaGliomaMagnetic Resonance ImagingMRIcs.CVcs.LGReceptors, Chimeric Antigenbevacizumab
On Valency
published · living versionsW_ctyr365s·v1 · currentpublished
Identifying the Best Machine Learning Algorithms for Brain Tumor Segmentation, Progression Assessment, and Overall Survival Prediction in the BRATS Challenge
with Spyridon Bakas, Mauricio Reyes, Andras Jakab, Stefan Bauer +422
1 version
Preprints & journals
167 papers in the corpus · 1999–2026Prognostic Significance of Contrast Enhancement in Newly Diagnosed Grade 2 IDH-mutant Glioma.42886524 · Nakhate, Vihang, Lasica, Aleksandra B, Aker, Loai et al.2026 · 0 citationsNeuro-oncology. 2026
A deep learning algorithm for fully automated volumetric measurement of meningioma burden.42487903 · Cleveland, Mason C, Kim, Albert E, McNeal, Thomas N et al.2026 · 0 citationsNeuro-oncology advances. 2026;8(1):vdag137
Weak supervision of H&E slides reveals systems-level biology and functional states that govern therapeutic resistance.42146619 · Goncalves, Tiago, Pulido, Dagoberto, Perrino, Carmen M et al.2026 · 0 citationsbioRxiv : the preprint server for biology. 2026
TRACED: In vivo imaging of extracellular intrinsic diffusivity, tortuosity, cell size distribution and cell density in human glioma patients.42147723 · Marchant, Joshua K, Lee, Hong-Hsi, Gerstner, Elizabeth R et al.2026 · 0 citationsArXiv. 2026
CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.42016022 · Zhang, Shuodan, Ozer, Byram H, Omuro, Antonio et al.2026 · 0 citationsNeuro-oncology advances. 2026;8(1):vdag016
Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma.41397912 · Youssef, Gilbert, Aquilanti, Elisa, Miller, Julie J et al.2026 · 7 citationsNeuro-oncology. 2026;28(3):752-764
Letter to the EditorTumor-infiltrating lymphocyte therapy generated from melanoma brain metastasis: Proof-of-concept for CNS-derived cellular immunotherapy.41397919 · Grewal, Eric P, Steuart, Samuel J, Liu, Baolin et al.2026 · 0 citationsNeuro-oncology. 2026;28(3):815-818
Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.41666344 · Blakeley, Jaishri O, Ye, Xiaobu, Duda, Dan G et al.2026 · 0 citationsJournal of clinical oncology : official journal of the American Society of Clinical Oncology. 2026;44(8):723
Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial.41545592 · Brastianos, Priscilla K, Dooley, Katharine, Geyer, Susan et al.2026 · 7 citationsNature medicine. 2026;32(2):717-724
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells.40579924 · Ramapriyan, Rishab, Barker, Fred G, Richardson, Leland G et al.2026 · 6 citationsNeuro-oncology. 2025;27(12):3104-3118
Limited evidence of pseudoprogression following immune checkpoint inhibitor (ICI) therapy in glioblastoma.41613042 · Rhee, John Y, Ospina Botero, Juan Pablo, Nelson, Thomas et al.2026 · 2 citationsNeuro-oncology advances. 2026;8(1):vdaf232
ESPWA: a deep learning-enabled tool for precision-based use of endocrine therapy in resource-limited settings.40909747 · Pulido-Arias, Dagoberto, Henderson, Rebecca, Millien, Christophe et al.2025 · 0 citationsbioRxiv : the preprint server for biology. 2025
A single-institution study of the natural history of fibroblast growth factor receptor-altered gliomas.41080200 · Viera, Maya, Mount, Christopher W, Dias-Santagata, Dora et al.2025 · 0 citationsNeuro-oncology practice. 2025;12(5):797-802
A review of deep learning for brain tumor analysis in MRI.39753730 · Dorfner, Felix J, Patel, Jay B, Kalpathy-Cramer, Jayashree et al.2026 · 203 citationsNPJ precision oncology. 2025;9(1):2
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes.39911703 · Lanman, Tyler A, Youssef, Gilbert, Huang, Raymond et al.2025 · 14 citationsNeuro-oncology advances. 2025;7(1):vdae227
Clinical progress in the development of CAR T cells to treat malignant glioma.39695004 · Grewal, Eric P, Nahed, Brian V, Carter, Bob S et al.2025 · 7 citationsJournal of neuro-oncology. 2025;171(3):571-579
Brain volume loss after cranial irradiation: a controlled comparison study between photon vs proton radiotherapy for WHO grade 2-3 gliomas.39400662 · Gardner, Melissa M, Winter, Sebastian F, Stahl, Franziska et al.2025 · 9 citationsJournal of neuro-oncology. 2025;171(2):351-363
Infusion of CARv3-TEAM-E T Cells in Glioblastoma. Reply.38924746 · Gerstner, Elizabeth R, Choi, Bryan D, Curry, William T2024 · 2 citationsThe New England journal of medicine. 2024;390(24):2330-2331
Analysis of the 2024 BraTS Meningioma Radiotherapy Planning Automated Segmentation Challenge2405.18383v3 · Dominic LaBella, Valeriia Abramova, Mehdi Astaraki et al.2024 · 8 citationsarXiv
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance.38070147 · Kim, Albert E, Lou, Kevin W, Giobbie-Hurder, Anita et al.2024 · 8 citationsNeuro-oncology. 2024;26(5):965-974
Deep Learning-based Prediction of Breast Cancer Tumor and Immune Phenotypes from Histopathology2404.16397v1 · Tiago Goncalves, Dagoberto Pulido-Arias, Julian Willett et al.2024 · 3 citationsarXiv
Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?38649630 · Wang, Alexander F, Hsueh, Brian, Choi, Bryan D et al.2024 · 10 citationsCurrent treatment options in oncology. 2024;25(5):628-643
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.38252427 · Lim-Fat, Mary Jane, Iorgulescu, J Bryan, Rahman, Rifaquat et al.2024 · 7 citationsClinical cancer research : an official journal of the American Association for Cancer Research. 2024;30(7):1327-1337
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma.38477966 · Choi, Bryan D, Gerstner, Elizabeth R, Frigault, Matthew J et al.2024 · 457 citationsThe New England journal of medicine. 2024;390(14):1290-1298
Discontinuation of Antiseizure Medications in Patients With Brain Tumors.38290092 · Peters, Katherine B, Templer, Jessica, Gerstner, Elizabeth R et al.2024 · 16 citationsNeurology. 2024;102(4):e209163
Expert-centered Evaluation of Deep Learning Algorithms for Brain Tumor Segmentation.38197800 · Hoebel, Katharina V, Bridge, Christopher P, Ahmed, Sara et al.2024 · 13 citationsRadiology. Artificial intelligence. 2024;6(1):e220231
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.37402650 · Karschnia, Philipp, Arrillaga-Romany, Isabel C, Eichler, April et al.2023 · 45 citationsNeuro-oncology. 2023;25(12):2239-2249
The Role of Antibody-Based Therapies in Neuro-Oncology.37987252 · Ramapriyan, Rishab, Sun, Jing, Curry, Annabel et al.2026 · 16 citationsAntibodies (Basel, Switzerland). 2023;12(4)
Not without Context-A Multiple Methods Study on Evaluation and Correction of Automated Brain Tumor Segmentations by Experts.37951777 · Hoebel, Katharina V, Bridge, Christopher P, Kim, Albert et al.2024 · 5 citationsAcademic radiology. 2024;31(4):1572-1582
Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy.37693537 · Kim, Albert E, Lou, Kevin W, Giobbie-Hurder, Anita et al.2023 · 0 citationsbioRxiv : the preprint server for biology. 2023
Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients.37327319 · Ly, K Ina, Richardson, Leland G, Liu, Mofei et al.2026 · 22 citationsClinical cancer research : an official journal of the American Association for Cancer Research. 2023;29(16):3017-3025
BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas.37437144 · Brastianos, Priscilla K, Twohy, Erin, Geyer, Susan et al.2023 · 145 citationsThe New England journal of medicine. 2023;389(2):118-126
Clinical management of seizures in patients with meningiomas: Efficacy of surgical resection for seizure control and patient-tailored postoperative anti-epileptic drug management.37287578 · Peart, Rodeania, Melnick, Kaitlyn, Cibula, Jean et al.2023 · 9 citationsNeuro-oncology advances. 2023;5(Suppl 1):i58-i66
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results.37268724 · Brastianos, Priscilla K, Kim, Albert E, Giobbie-Hurder, Anita et al.2023 · 66 citationsNature medicine. 2023;29(7):1728-1737
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma.37027809 · Youssef, Gilbert, Rahman, Rifaquat, Bay, Camden et al.2023 · 65 citationsJournal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023;41(17):3160-3171
Imaging of Brain Tumors.36795877 · Jordan, Justin T, Gerstner, Elizabeth R2023 · 5 citationsContinuum (Minneapolis, Minn.). 2023;29(1):171-193
Labeling T Cells to Track Immune Response to Immunotherapy in Glioblastoma.36828374 · Rhee, John Y, Ghannam, Jack Y, Choi, Bryan D et al.2023 · 4 citationsTomography (Ann Arbor, Mich.). 2023;9(1):274-284
Accelerated and quantitative three-dimensional molecular MRI using a generative adversarial network.36585915 · Weigand-Whittier, Jonah, Sedykh, Maria, Herz, Kai et al.2023 · 26 citationsMagnetic resonance in medicine. 2023;89(5):1901-1914
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma.36751672 · Schmidts, Andrea, Srivastava, Ambike A, Ramapriyan, Rishab et al.2026 · 81 citationsNeuro-oncology advances. 2023;5(1):vdac185
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations.36288512 · Brastianos, Priscilla K, Twohy, Erin L, Gerstner, Elizabeth R et al.2023 · 115 citationsJournal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023;41(3):618-628
Regional healthy brain activity, glioma occurrence and symptomatology.36130310 · Numan, Tianne, Breedt, Lucas C, Maciel, Bernardo de A P C et al.2022 · 45 citationsBrain : a journal of neurology. 2022;145(10):3654-3665
Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma.36071927 · El-Abtah, Mohamed E, Talati, Pratik, Fu, Melanie et al.2026 · 11 citationsNeuro-oncology advances. 2022;4(1):vdac128
Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition.35706413 · Alvarez-Breckenridge, Christopher, Markson, Samuel C, Stocking, Jackson H et al.2022 · 52 citationsCancer immunology research. 2022;10(8):996-1012
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.35380705 · Ellingson, Benjamin M, Gerstner, Elizabeth R, Lassman, Andrew B et al.2022 · 22 citationsNeuro-oncology. 2022;24(8):1219-1229
QU-BraTS: MICCAI BraTS 2020 Challenge on Quantifying Uncertainty in Brain Tumor Segmentation - Analysis of Ranking Scores and Benchmarking Results.36998700 · Mehta, Raghav, Filos, Angelos, Baid, Ujjwal et al.2024 · 61 citationsThe journal of machine learning for biomedical imaging. 2022;2022
Magnetic resonance spectroscopic imaging for detecting metabolic changes in glioblastoma after anti-angiogenic therapy-a systematic literature review.35892047 · El-Abtah, Mohamed E, Talati, Pratik, Dietrich, Jorg et al.2022 · 1 citationNeuro-oncology advances. 2022;4(1):vdac103
Volumetric measurements in low-grade glioma: Are we there yet?35089341 · Gerstner, Elizabeth R2022 · 4 citationsNeuro-oncology. 2022;24(5):779-780
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.35289329 · Brastianos, Priscilla K, Kim, Albert E, Giobbie-Hurder, Anita et al.2022 · 109 citationsNature communications. 2022;13(1):1325
Reply to Koekkoek et al. concerning SNO and EANO practice guideline update.35079807 · Walbert, Tobias, Gerstner, Elizabeth R2022 · 0 citationsNeuro-oncology. 2022;24(3):501
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial.35088051 · Griguer, Corinne E, Oliva, Claudia R, Coffey, Christopher S et al.2022 · 4 citationsNeuro-oncology advances. 2022;4(1):vdab186
Career total: 454 works. 167 are in this corpus.Showing the 50 most recent.
Profile built from the corpus for this byline.
Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.